[1] Nagle PW, Plukker JTM, Muijs CT, et al.Patient-derived tumor organoids for prediction of cancer treatment response[J]. Semin Cancer Biol, 2018, 53:258-264. [2] Bleijs M, van de Wetering M, Clevers H. Xenograft and organoid model systems in cancer research[J]. EMBO J, 2019, 38(15):e101654. [3] Jung J, Seol HS.The generation and application of patient-derived xenograft model for cancer research[J]. Cancer Res Treat, 2018, 50(1):1-10. [4] Tuveson D.Cancer modeling meets human organoid technology[J]. Science, 2019, 364(6444):952-955. [5] Lindberg K, Brown ME, Chaves HV, et al.In vitro propagation of human ocular surface epithelial cells for transplantation[J]. Invest Ophthalmol Vis Sci, 1993, 34(9):2672-2679. [6] Pellegrini G, Traverso CE, Franzi AT, et al.Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium[J]. Lancet, 1997, 349(9057):990-993. [7] Toshiro S, Robert GV, Hugo JS, et al.Single Lgr5 stem cells buildcrypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459(7244):262-265. [8] Sato T, Stange DE, Ferrante M, et al.Long-term expansionof epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium[J]. Gastroenterology, 2011, 141(5):1762-1772. [9] van de Wetering M, Francies HE, Francis JM, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients[J]. Cell, 2015, 161(4):933-945. [10] Fujii M, Shimokawa M, Date S, et al.A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis[J]. Cell Stem Cell, 2016, 18(6):827-838. [11] Gao D, Vela I, Sboner A, et al.Organoid cultures derived from patients with advanced prostate cancer[J]. Cell, 2014, 159(1):176-187. [12] Mondrinos MJ, Jones PL, Finck CM, et al.Engineering de novo assembly of fetal pulmonary organoids[J]. Tissue Eng Part A, 2014, 20(21/22):2892-2907. [13] Broutier L, Mastrogiovanni G, Verstegen MM, et al.Human primary liver cancer-derived organoid cultures for disease modeling and drug screening[J]. Nat Med, 2017, 23(12):1424-1435. [14] Turco MY, Gardner L, Hughes J, et al.Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium[J]. Nat Cell Biol, 2017, 19(5):568-577. [15] Vlachogiannis G, Hedayat S, Vatsiou A, et al.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science, 2018, 359(6378):920-926. [16] Sachs N, de Ligt J, Kopper O, et al. A living biobank of breast cancer organoids captures disease heterogeneity[J]. Cell, 2018,172(1/2):373-386. [17] Lee SH, Hu W, Matulay JT, et al.Tumor evolution and drug response in patient-derived organoid models of bladder cancer[J]. Cell, 2018, 173(2):515-528. [18] Li X, Francies HE, Secrier M, et al.Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics[J]. Nat Commun, 2018, 9(1):2983. [19] Kim M, Mun H, Sung CO, et al.Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening[J]. Nat Commun, 2019, 10(1):3991. [20] Grassi L, Alfonsi R, Francescangeli F, et al.Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases[J]. Cell Death Dis, 2019, 10(3):201. [21] Kopper O, de Witte CJ, L hmussaar K, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity[J]. Nat Med, 2019, 25(5):838-849. [22] Rios AC, Clevers H.Imaging organoids: a bright future ahead[J]. Nat Methods, 2018, 15(1):24-26. [23] Drost J, van Jaarsveld RH, Ponsioen B, et al. Sequential cancer mutations in cultured human intestinal stem cells[J]. Nature, 2015, 521(7550):43-47. [24] Nanki K,Toshimitsu K,Takano A,et al.Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis[J]. Cell, 2018, 174(4):856-869. [25] De Flora S, Crocetti E, Bonanni P, et al.Incidence of infection-associated cancers in Italy and prevention strategies[J]. Epidemiol Prev, 2015, 39(4 Suppl 1):14-20. [26] Buti L, Ruiz-Puig C, Sangberg D, et al.CagA-ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids[J]. Proc Natl Acad Sci U S A, 2020, 117(5):2645-2655. [27] Ramani S, Crawford SE, Blutt SE.Human organoid cultures: transformative new tools for human virus studies[J]. Curr Opin Virol, 2018, 29:79-86. [28] Stratton MR, Campbell PJ.The cancer genome[J]. Nature, 2009, 458(7239):719-724. [29] Huch M, Gehart H, van Boxtel R, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell, 2015, 160(1/2):299-312. [30] Chio IIC, Jafarnejad SM, Ponz-Sarvise M, et al.NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer[J]. Cell, 2016, 166(4):963-976. [31] Roerink SF, Sasaki N, Lee-Six H, et al.Intra-tumour diversification in colorectal cancer at the single-cell level[J]. Nature, 2018, 556(7702):457-462. [32] Rizvi NA, Hellmann MD, Snyder A, et al.Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer[J]. Science, 2015, 348(6230):124-128. [33] Tuveson D, Clevers H.Cancer modeling meets human organoid technology[J]. Science, 2019, 364(6444):952-955. [34] Dijkstra KK, Cattaneo CM, Weeber F, et al.Generation of tumor-peactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids[J]. Cell, 2018, 174(6):1586-1598. [35] Str nen E, Toebes M, Kelderman S, et al. Targeting of cancer neoantigens with donor-derived T cell receptor repertoires[J]. Science, 2016, 352(6291):1337-1341. [36] Tajima A, Pradhan I, Trucco M.Restoration of thymus function with bioengineered thymus organoids[J]. Curr Stem Cell Rep, 2016, 2(2):128-139. [37] Merker JD, Oxnard GR, Compton C, et al.Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review[J]. J Clin Oncol, 2018, 36(16):1631-1641. [38] Praharaj PP, Bhutia SK, Nagrath S, et al.Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine[J]. Biochim Biophys Acta Rev Cancer, 2018, 1869(2):117-127. [39] Hubert CG, Rivera M, Spangler LC, et al.A three-dimensional organoid culture system derived from human glioblas tomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo[J]. Cancer Res, 2016, 76(8):2465-2477. |